These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24784227)

  • 1. UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers.
    Carmo-Gonçalves P; Pinheiro AS; Romão L; Cortines J; Follmer C
    Amyloid; 2014 Sep; 21(3):163-74. PubMed ID: 24784227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain.
    Coelho-Cerqueira E; de Araújo Correia Campos C; Follmer C
    Biochem Biophys Res Commun; 2019 Feb; 509(2):367-372. PubMed ID: 30591215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.
    Carmo-Gonçalves P; do Nascimento LA; Cortines JR; Eliezer D; Romão L; Follmer C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):295-301. PubMed ID: 30249394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions.
    Zhou W; Long C; Reaney SH; Di Monte DA; Fink AL; Uversky VN
    Biochim Biophys Acta; 2010 Mar; 1802(3):322-30. PubMed ID: 20026206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein.
    Hokenson MJ; Uversky VN; Goers J; Yamin G; Munishkina LA; Fink AL
    Biochemistry; 2004 Apr; 43(15):4621-33. PubMed ID: 15078109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early events in copper-ion catalyzed oxidation of α-synuclein.
    Tiwari MK; Leinisch F; Sahin C; Møller IM; Otzen DE; Davies MJ; Bjerrum MJ
    Free Radic Biol Med; 2018 Jun; 121():38-50. PubMed ID: 29689296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein.
    Rodríguez EE; Arcos-López T; Trujano-Ortiz LG; Fernández CO; González FJ; Vela A; Quintanar L
    J Biol Inorg Chem; 2016 Sep; 21(5-6):691-702. PubMed ID: 27422629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure.
    Ponzini E; De Palma A; Cerboni L; Natalello A; Rossi R; Moons R; Konijnenberg A; Narkiewicz J; Legname G; Sobott F; Mauri P; Santambrogio C; Grandori R
    J Biol Chem; 2019 Apr; 294(14):5657-5665. PubMed ID: 30755483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites.
    Binolfi A; Limatola A; Verzini S; Kosten J; Theillet FX; Rose HM; Bekei B; Stuiver M; van Rossum M; Selenko P
    Nat Commun; 2016 Jan; 7():10251. PubMed ID: 26807843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine oxidation, alpha-synuclein and Parkinson's disease.
    Glaser CB; Yamin G; Uversky VN; Fink AL
    Biochim Biophys Acta; 2005 Jan; 1703(2):157-69. PubMed ID: 15680224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
    Kardani J; Roy I
    ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
    Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
    PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific interaction between α-synuclein and membranes probed by NMR-observed methionine oxidation rates.
    Maltsev AS; Chen J; Levine RL; Bax A
    J Am Chem Soc; 2013 Feb; 135(8):2943-6. PubMed ID: 23398174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines.
    Alvarez-Castelao B; Goethals M; Vandekerckhove J; Castaño JG
    Biochim Biophys Acta; 2014 Feb; 1843(2):352-65. PubMed ID: 24315858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding.
    Yamaguchi Y; Masuda M; Sasakawa H; Nonaka T; Hanashima S; Hisanaga S; Kato K; Hasegawa M
    J Mol Biol; 2010 Jan; 395(3):445-56. PubMed ID: 19895818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro methionine oxidation of Escherichia coli-derived human stem cell factor: effects on the molecular structure, biological activity, and dimerization.
    Hsu YR; Narhi LO; Spahr C; Langley KE; Lu HS
    Protein Sci; 1996 Jun; 5(6):1165-73. PubMed ID: 8762148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
    Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
    Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z
    J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of copper-α-synuclein peptide complexes relevant to Parkinson's disease.
    Dell'Acqua S; Pirota V; Anzani C; Rocco MM; Nicolis S; Valensin D; Monzani E; Casella L
    Metallomics; 2015 Jul; 7(7):1091-102. PubMed ID: 25865825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.